News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

SGLT2 inhibitors reduce HCC risk in T2DM patients with CHB
18 May 2023
byChristina Lau
The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors is associated with a reduced risk of incident hepatocellular carcinoma (HCC) in patients with coexisting type 2 diabetes mellitus (T2DM) and chronic hepatitis B (CHB), a territory-wide cohort study in Hong Kong has shown.
18 May 2023

Triple, quadruple combos a useful strategy for early management of hypertension
17 May 2023
Low-dose drug combinations that incorporate between three and four blood pressure (BP)-lowering medications appear to be well tolerated and effective for the initial or early management of hypertension, according to the results of a systematic review and meta-analysis.
17 May 2023






